N-acetylcysteine (NAC) facilitates motor learning in infants of diabetic mothers (IDM) failing oral feeds treated with transcutaneous auricular vagus nerve stimulation (taVNS)

N-acetylcysteine (NAC) facilitates motor learning in infants of diabetic mothers (IDM) failing oral feeds treated with transcutaneous auricular vagus nerve stimulation (taVNS)

Bibliographic Details
Main Authors:	Dorothea Jenkins, Alyssa Brennan, Bashar Badran, Mark George, Donald Wiest, Garner Sandra
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Brain Stimulation
Online Access:	http://www.sciencedirect.com/science/article/pii/S1935861X23007593

Similar Items

Parametric modulation of the heart and brain using transcutaneous auricular vagus nerve stimulation (taVNS)
by: Bashar Badran
Published: (2021-11-01)

Modulatory effects of transcutaneous auricular vagus nerve stimulation (taVNS) on attentional processes
by: Haoyu Yang, et al.
Published: (2023-12-01)

Transcutaneous auricular vagus nerve stimulation (taVNS) decreases heart rate acutely in neonatal rats
by: Melanie W. Gail, et al.
Published: (2023-09-01)

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) Attenuates Early Increases in Heart Rate Associated with the Cold Pressor Test
by: Christopher Austelle, et al.
Published: (2023-01-01)

The effect of non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) on hypoxic-ischemic injury in newborn rats
by: Melanie Wiley, et al.
Published: (2021-11-01)

Safety of transcutaneous auricular vagus nerve stimulation (taVNS): a systematic review and meta-analysis
by: Angela Yun Kim, et al.
Published: (2022-12-01)

The effect of transcutaneous auricular vagus nerve stimulation (taVNS) in stroke patients by Near infrared spectroscopy (NIRS)
by: Rong-Jang Lin, et al.
Published: (2025-01-01)

A pooled analysis of the side effects of non-invasive Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
by: Manon Giraudier, et al.
Published: (2025-02-01)

439 The effect of non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) on hypoxic-ischemic injury in newborn rats
by: Melanie Gail Wiley, et al.
Published: (2022-04-01)

Transcutaneous auricular vagus nerve stimulation may benefit from the addition of N-acetylcysteine to facilitate motor learning in infants of diabetic mothers failing oral feeds
by: Dorothea D. Jenkins, et al.
Published: (2024-05-01)

Tonic and phasic transcutaneous auricular vagus nerve stimulation (taVNS) both evoke rapid and transient pupil dilation
by: Lina Skora, et al.
Published: (2024-03-01)

Modulating effect of transcutaneous auricular vagus nerve stimulation (taVNS) on salivary alpha-amylase as indirect noradrenergic marker
by: Manon Giraudier, et al.
Published: (2023-01-01)

A pilot randomized controlled trial of supervised, at-home, self-administered transcutaneous auricular vagus nerve stimulation (taVNS) to manage long COVID symptoms
by: Bashar W. Badran, et al.
Published: (2022-08-01)

Exploring the efficacy of Transcutaneous Auricular Vagus nerve stimulation (taVNS) in modulating local and systemic inflammation in experimental models of colitis
by: Fatemeh Hesampour, et al.
Published: (2024-12-01)

Using transcutaneous auricular vagus nerve stimulation (taVNS) for promoting neuroplasticity: putative mechanisms, possible biomarkers and potential clinical applications
by: Fioravante Capone, et al.
Published: (2025-01-01)

Evaluating phasic transcutaneous vagus nerve stimulation (taVNS) with pupil dilation: the importance of stimulation intensity and sensory perception
by: Mareike Ludwig, et al.
Published: (2024-10-01)

Synergistic effects of simultaneous transcranial direct current stimulation (tDCS) and transcutaneous auricular vagus nerve stimulation (taVNS) on the brain responses
by: Jin-Bo Sun, et al.
Published: (2021-03-01)

What are the best taVNS parameters? Understanding the waveform and ear target considerations to optimize taVNS
by: Bashar Badran, et al.
Published: (2025-01-01)

An assessor-blinded, randomized comparative trial of transcutaneous auricular vagus nerve stimulation (taVNS) combined with cranial electroacupuncture vs. citalopram for depression with chronic pain
by: Shaoyuan Li, et al.
Published: (2022-08-01)

Transcutaneous auricular vagus nerve stimulation induces stabilizing modifications in large-scale functional brain networks: towards understanding the effects of taVNS in subjects with epilepsy
by: Randi von Wrede, et al.
Published: (2021-04-01)

Efficacy of Transcutaneous Auricular Vagal Nerve Stimulation (taVNS) on Anxiety and Quality of Sleep Among School Teachers
by: Vignesh Srinivasan, et al.
Published: (2024-09-01)

Pairing taVNS and CIMT is feasible and may improve upper extremity function in infants
by: Kelly McGloon, et al.
Published: (2024-02-01)

Locus coeruleus tyrosine hydroxylase positive neurons mediated the peripheral and central therapeutic effects of transcutaneous auricular vagus nerve stimulation (taVNS) in MRL/lpr mice
by: Hongjie Lv, et al.
Published: (2024-01-01)

Evidence for a modulating effect of transcutaneous auricular vagus nerve stimulation (taVNS) on salivary alpha-amylase as indirect noradrenergic marker: A pooled mega-analysis
by: Manon Giraudier, et al.
Published: (2022-11-01)

Diffusional kurtosis imaging reveals taVNS facilitates microstructural changes in the developing neonatal brain
by: Hunter Moss, et al.
Published: (2021-11-01)

Understanding the anatomical substrates and neurophysiological effects of transcutaneous auricular vagus nerve stimulation
by: Bashar Badran
Published: (2021-11-01)

Early indices of safety related to the effects of transcutaneous auricular vagus nerve stimulation on oropharyngeal swallowing in infants
by: Heather C. McGhee, et al.
Published: (2023-01-01)

Use of non-invasive transcutaneous auricular vagus nerve stimulation: neurodevelopmental and sensory follow-up
by: Turki Aljuhani, et al.
Published: (2023-11-01)

Transcranial Auricular Vagus Nerve Stimulation (taVNS) and Ear-EEG: Potential for Closed-Loop Portable Non-invasive Brain Stimulation
by: Philipp Ruhnau, et al.
Published: (2021-06-01)

Combining taVNS with early CIMT to improve health outcomes of infants: a case report
by: Kelly McGloon, et al.
Published: (2023-03-01)

The Effect of Transcutaneous Auricular Vagal Nerve Stimulation (taVNS) on P3 Event-Related Potentials during a Bayesian Oddball Task
by: Claire V. Warren, et al.
Published: (2020-06-01)

Effects of transcutaneous auricular vagus nerve stimulation (tVNS) on balance in patient with chronic lower back pain
by: Meisy Andriana, et al.
Published: (2024-06-01)

Transcutaneous auricular VNS to for myelin repair after demyelination injury
by: Cristin Welle, et al.
Published: (2025-01-01)

First in-neonate use of non-invasive transcutaneous auricular vagus nerve stimulation: 18-month neurodevelopmental and sensory follow-up
by: Turki Aljuhani, et al.
Published: (2023-01-01)

Electroencephalographic Patterns in taVNS: A Systematic Review
by: Anna Carolyna L. Gianlorenco, et al.
Published: (2022-09-01)

At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms.
by: Sarah Huffman, et al.
Published: (2021-11-01)

Neuromodulation in Young Infants with Hemiplegia: Combining taVNS and Constraint Induced Movement Therapy (CIMT)
by: Kelly McGloon, et al.
Published: (2025-01-01)

Increasing the number of daily stimulation sessions administered during taVNS-paired bottle feeding speeds response time in newborns with feeding difficulty
by: Lauren Adams, et al.
Published: (2021-11-01)

Efficacy and safety of transcutaneous auricular vagus nerve stimulation (ta-VNS) in the treatment of tinnitus: protocol for an updated systematic review and meta-analysis
by: Xiaoqi Lin, et al.
Published: (2024-05-01)

Functional MRI as a biomarker discovery platform for taVNS
by: Roberta Sclocco, et al.
Published: (2025-01-01)